Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology... see more

Add To Watchlist

Bullboard (TSX:CPH)

View:

Comment by nozzpackon Nov 15, 2020 1:40pm

RE:RE:Bausch Reports Strong Sales Growth for Trulance

Could not find Trulance sales for Q3 but did find sales for Q1 which grew by 52% to $19 m US Q1 is the weakest quarter of the year, due to annual insurance deductions having to be paid by the ...more

119

Discussion

Comment by nozzpackon Nov 15, 2020 1:22pm

RE:RE:Proxy Based Fair Value

Exactly my opinion ..that the share price is being contained for a purpose. Either merger or takeover .

112

Discussion

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Comment by r0naldon Nov 15, 2020 10:34am

RE:Proxy Based Fair Value

Thank you for this comparison! Always good to get confirmation that Cipher is undervalued. I've been following for quite some time now and the trading in its shares is very strange. There is a ...more

167

Discussion

Post by nozzpackon Nov 14, 2020 12:52pm

Proxy Based Fair Value

I use Biosyent ( RX...$7.07 ) as an excellent proxy for Cipher as both have excellent balance sheets and no debt and growth has been muted.. The comparison with RX is very instructive as to ...more

870

Discussion

Comment by nozzpackon Nov 14, 2020 9:35am

RE:Bausch Reports Strong Sales Growth for Trulance

Bausch did not report quarterly sales of Trulance for 2020 but 2019 Trulance sales were $55 million US = $70 m CAD, which was not for a full year . As sales efforts in the US are still ramping up ...more

178

Discussion

Post by nozzpackon Nov 14, 2020 9:13am

Non Capital Losses ,Tax Credits, SRED credits ..$400 m CAD

According to Canadian tax law, all of Cphers non capital tax losses, ITC credits and SRED credits, totally approx $280 m US ( $400 m in CAD ), will be beneficial to an acquirer after change of control ...more

799

Post by nozzpackon Nov 14, 2020 9:00am

Investment Tax Credits Also Beneficial to Suitor

Basically, ITCs earned before the change of control from a business can be carried forward to offset taxes after the change of control resulting from income from the same or similar business ...more

767

Post by nozzpackon Nov 14, 2020 8:53am

Forget Generic Launch of Absorica

Price and preference for Absorica will stop any launch of a generic of Absorica ...from the CC.. We are preparing , in the event of a launch of a generic to be able to come out with an authorized ...more

784

Post by nozzpackon Nov 14, 2020 8:45am

Bausch Reports Strong Sales Growth for Trulance

Reported revenue for Trulance (plecanatide) increased by 57 per cent compared with the third quarter of 2019. From this perspective , it is easy to understand why they want Trulance for their ...more

822

Discussion

Post by nozzpackon Nov 14, 2020 8:12am

Acquisition Rules for Change of Control Non capital losses

In Canada, Non-capital losses from a business before the change of control may be carried forward to years after the change of control, but only if the same business is carried on after the change of ...more

775

Comment by nozzpackon Nov 13, 2020 7:09pm

RE:RE:RE:Tax Losses

The Cardiome subsidiary has non-capital losses of $211,390,000 ,investment tax credits of $13,587,000 and SR&ED expenditures of $54,859,00 The non-capital losses expire in varying ...more

Discussion

Comment by r0naldon Nov 13, 2020 5:37pm

RE:RE:Tax Losses

That is the number I recalled. I was wrong though, factually it something like $ 210 million. "The Company has various non-capital losses of approximately $210 million and proactively works ...more

111

Discussion

Post by nozzpackon Nov 13, 2020 4:57pm

Transcript of today’s CC

https://seekingalpha.com/article/4388875-cipher-pharmaceuticals-cphrf-ceo-craig-mull-on-q3-2020-results-earnings-call-transcript?page=4 Hi, good morning. Thanks for taking my questions ...more

776

Comment by alfhopeon Nov 13, 2020 4:38pm

RE:Tax Losses

Where do you see tax losses of $ 100 million ? Dont understand.

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSX:CPH)